Arbutus Biopharma Corporation (ABUS)
NASDAQ · Healthcare
Arbutus Biopharma Corporation Revenue 2011–2025
Arbutus Biopharma Corporation annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Arbutus Biopharma Corporation revenue for the quarter ending March 31, 2026 was 179.1 M, a 10054.54% increase year-over-year.
- Arbutus Biopharma Corporation revenue for the twelve months ending March 31, 2026 was 192.2 M, a 1976.26% increase year-over-year.
- Arbutus Biopharma Corporation annual revenue for 2025 was 14.1 M, a 128.21% increase from 2024.
- Arbutus Biopharma Corporation annual revenue for 2024 was 6.2 M, a 65.98% decrease from 2023.
- Arbutus Biopharma Corporation annual revenue for 2023 was 18.1 M, a 53.51% decrease from 2022.
- Arbutus Biopharma Corporation annual revenue for 2022 was 39.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arbutus Biopharma Corporation Revenue — FAQ
Arbutus Biopharma Corporation (ABUS) revenue over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Arbutus Biopharma Corporation's revenue?
Arbutus Biopharma Corporation (ABUS) reported revenue of $14M for fiscal 2025.
Where can I see ABUS's revenue history?
The chart and table above show Arbutus Biopharma Corporation's revenue by year and by quarter, including the growth rate.